References
- Jabbour E, Kantarjian HM, Abruzzo LV, O'Brien S, Garcia-Manero G, Verstovsek S, . Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 2007;110:2991–5.
- Appelbaum FR, Najfeld V, Singer JW. Chronic myelogenous leukemia. Prolonged survival with spontaneous decline in the frequency of Ph1-positive cells and subsequent development of mixed Ph1-positive and Ph1-negative blast crisis. Cancer 1983;51:149–53.
- Bose S, Chowdhry VP, Saxena R, Kucheria K. Lymphoid blast crisis during complete cytogenetic remission following interferon-alpha and hydroxyurea therapy. Acta Haematol 1997;98:155–9.
- Dawson L, Slater R, Hagemeijer A, Langerak AW, Willemze R, Kluin-Nelemans JC. Secondary T-acute lymphoblastic leukaemia mimicking blast crisis in chronic myeloid leukaemia. Br J Haematol 1999;106:104–6.
- Au WY, Lie AK, Ma SK, Wan TS, Liang R, Leung YH, . Philadelphia (Ph) chromosome-positive chronic myeloid leukaemia relapsing as Ph-negative leukaemia after allogeneic bone marrow transplantation. Br J Haematol 2001;114:365–8.
- Zhang X, Ji L, Liu S, Wang J. Ph-negative acute lymphocytic leukemia occurring after interferon therapy for Ph-positive chronic myelocytic leukemia. Leuk Res 2003;27:367–9.
- Jin Huh H, Won Huh J, Myong Seong C, Lee M, Soon Chung W. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome. Am J Hematol 2003;74:218–20.
- Cherrier-De Wilde S, Rack K, Vannuffel P, Delannoy A, Hagemeijer A. Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission. Leukemia 2003;17:2046–8.
- Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobson RJ, Hansen JA. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 1981;58:158–63.
- Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, . Mutation in TET2 in myeloid cancers. N Engl J Med 2009;360:2289–301.